276 related articles for article (PubMed ID: 30917675)
1. Pharmacology Update: Low-Dose Naltrexone as a Possible Nonopioid Modality for Some Chronic, Nonmalignant Pain Syndromes.
Trofimovitch D; Baumrucker SJ
Am J Hosp Palliat Care; 2019 Oct; 36(10):907-912. PubMed ID: 30917675
[TBL] [Abstract][Full Text] [Related]
2. The Safety and Efficacy of Low-Dose Naltrexone in the Management of Chronic Pain and Inflammation in Multiple Sclerosis, Fibromyalgia, Crohn's Disease, and Other Chronic Pain Disorders.
Patten DK; Schultz BG; Berlau DJ
Pharmacotherapy; 2018 Mar; 38(3):382-389. PubMed ID: 29377216
[TBL] [Abstract][Full Text] [Related]
3. Low-Dose Naltrexone for Chronic Pain: Update and Systemic Review.
Kim PS; Fishman MA
Curr Pain Headache Rep; 2020 Aug; 24(10):64. PubMed ID: 32845365
[TBL] [Abstract][Full Text] [Related]
4. Clinical utility of the cold pressor test: evaluation of pain patients, treatment of opioid-induced hyperalgesia and fibromyalgia with low dose naltrexone.
Oaks Z; Stage A; Middleton B; Faraone S; Johnson B
Discov Med; 2018 Nov; 26(144):197-206. PubMed ID: 30695679
[TBL] [Abstract][Full Text] [Related]
5. The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain.
Younger J; Parkitny L; McLain D
Clin Rheumatol; 2014 Apr; 33(4):451-9. PubMed ID: 24526250
[TBL] [Abstract][Full Text] [Related]
6. The Utilization of Low Dose Naltrexone for Chronic Pain.
Poliwoda S; Noss B; Truong GTD; Creech ZA; Koushik SS; Urits I; Viswanath O
CNS Drugs; 2023 Aug; 37(8):663-670. PubMed ID: 37505425
[TBL] [Abstract][Full Text] [Related]
7. Low Dose Naltrexone in the Treatment of Fibromyalgia.
Metyas S; Chen CL; Yeter K; Solyman J; Arkfeld DG
Curr Rheumatol Rev; 2018; 14(2):177-180. PubMed ID: 28325149
[TBL] [Abstract][Full Text] [Related]
8. Featured Article: Serum [Met
Ludwig MD; Zagon IS; McLaughlin PJ
Exp Biol Med (Maywood); 2017 Sep; 242(15):1524-1533. PubMed ID: 28766982
[TBL] [Abstract][Full Text] [Related]
9. Low-dose naltrexone, an opioid-receptor antagonist, is a broad-spectrum analgesic: a retrospective cohort study.
Martin SJ; McAnally HB; Okediji P; Rogosnitzky M
Pain Manag; 2022 Sep; 12(6):699-709. PubMed ID: 35289682
[TBL] [Abstract][Full Text] [Related]
10. Low-Dose Naltrexone (LDN)-Review of Therapeutic Utilization.
Toljan K; Vrooman B
Med Sci (Basel); 2018 Sep; 6(4):. PubMed ID: 30248938
[TBL] [Abstract][Full Text] [Related]
11. [Low dose naltrexone for treatment of pain].
Plesner KB; Vægter HB; Handberg G
Ugeskr Laeger; 2015 Oct; 177(43):V03150248. PubMed ID: 26509454
[TBL] [Abstract][Full Text] [Related]
12. Enhancing acupuncture by low dose naltrexone.
Hesselink JM; Kopsky DJ
Acupunct Med; 2011 Jun; 29(2):127-30. PubMed ID: 21415049
[TBL] [Abstract][Full Text] [Related]
13. Low-dose naltrexone and opioid consumption: a drug utilization cohort study based on data from the Norwegian prescription database.
Raknes G; Småbrekke L
Pharmacoepidemiol Drug Saf; 2017 Jun; 26(6):685-693. PubMed ID: 28370746
[TBL] [Abstract][Full Text] [Related]
14. Low-Dose Naltrexone Use for Patients with Chronic Regional Pain Syndrome: A Systematic Literature Review.
Soin A; Soin Y; Dann T; Buenaventura R; Ferguson K; Atluri S; Sachdeva H; Sudarshan G; Akbik H; Italiano J
Pain Physician; 2021 Jul; 24(4):E393-E406. PubMed ID: 34213865
[TBL] [Abstract][Full Text] [Related]
15. Exploring the Role of Chronic Pain Clinics: Potential for Opioid Reduction.
Patwardhan A; Matika R; Gordon J; Singer B; Salloum M; Ibrahim M
Pain Physician; 2018 Nov; 21(6):E603-E610. PubMed ID: 30508991
[TBL] [Abstract][Full Text] [Related]
16. Oral naltrexone to enhance analgesia in patients receiving continuous intrathecal morphine for chronic pain: a randomized, double-blind, prospective pilot study.
Hamann S; Sloan P
J Opioid Manag; 2007; 3(3):137-44. PubMed ID: 18027539
[TBL] [Abstract][Full Text] [Related]
17. Nonopioid versus opioid agents for chronic neuropathic pain, rheumatoid arthritis pain, cancer pain and low back pain.
Noori SA; Aiyer R; Yu J; White RS; Mehta N; Gulati A
Pain Manag; 2019 Mar; 9(2):205-216. PubMed ID: 30681031
[TBL] [Abstract][Full Text] [Related]
18. Featured Article: Modulation of the OGF-OGFr pathway alters cytokine profiles in experimental autoimmune encephalomyelitis and multiple sclerosis.
Ludwig MD; Zagon IS; McLaughlin PJ
Exp Biol Med (Maywood); 2018 Feb; 243(4):361-369. PubMed ID: 29307283
[TBL] [Abstract][Full Text] [Related]
19. Low Dose Naltrexone in Dermatology.
Jaros J; Lio P
J Drugs Dermatol; 2019 Mar; 18(3):235-238. PubMed ID: 30909326
[TBL] [Abstract][Full Text] [Related]
20. Rethinking the role of opioids in the outpatient management of chronic nonmalignant pain.
Provenzano DA; Viscusi ER
Curr Med Res Opin; 2014 Oct; 30(10):2051-62. PubMed ID: 24809728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
